RESEARCH REVIEW
Glutathione and Skin Pigmentation
What human trials show
Executive snapshot
Research question
What do controlled human studies actually show about glutathione and skin pigmentation, and how much can be generalized across formulations and routes?
Mechanism
Glutathione participates in cellular redox chemistry and has been studied in relation to melanogenesis pathways.
Mechanistic plausibility does not make oral, topical and parenteral formulations interchangeable. This review keeps route and formulation attached to each source.
Evidence in the indexed literature
- Population
- Healthy medical students
- Protocol
- Oral glutathione or placebo
- Duration
- 4 weeks
- Primary outcome
- Melanin index at measured sites
- Result
- The publication reported lower melanin indices at some measured sites; findings were not uniform across every site.
- Women included
- Mixed-sex enrollment; Femetric has not yet extracted a verified female count.
- Population
- Healthy adults
- Protocol
- Oral glutathione at two dose levels or placebo
- Duration
- 6 months
- Primary outcome
- Glutathione concentrations in blood compartments and cells
- Result
- This study addressed systemic glutathione status rather than pigmentation efficacy and provides route/context support only.
- Women included
- Mixed-sex enrollment; sex-specific outcomes were not indexed by Femetric.
Women in the research
Women were included in the indexed human literature, but a verified female-participant count has not been extracted for every paper.
Femetric has not identified a source-supported sex-stratified pigmentation result in the indexed studies.
No female-specific dose structure is represented.
No female life-stage protocol is established by these records.
Representation and sex-specific reporting are different questions; inclusion alone does not establish female-specific outcomes.
What the research currently supports
Small controlled human studies provide a research signal worth indexing, but the evidence is not broad enough to treat formulation, route, dose and outcome as interchangeable.
Durability, clinical significance, formulation comparability and long-term outcomes remain uncertain in the indexed source set.
Larger preregistered trials with standardized pigmentation measures and transparent sex-specific reporting.